Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmaceutics
|
August 10, 2021
The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives
Aymara Sancho-Araiz, Victor Mangas-Sanjuan, Iñaki F Trocóniz
Clinical Pharmacology and Therapeutics
|
July 22, 2024
Disentangling Anti-Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab
Aymara Sancho-Araiz, Zinnia P Parra-Guillen, Iñaki F Troconiz, et al.
Journal of Clinical Pharmacology
|
May 2, 2025
A Systematic Evaluation of the Dosing Regimens for Approved Targeted Therapies and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma From a Project OPTIMUS Perspective
Zhiyuan Tan, Swantje Völler, Aymara Sancho-Araiz, et al.
Plos Computational Biology
|
October 4, 2023
Mechanistic characterization of oscillatory patterns in unperturbed tumor growth dynamics: The interplay between cancer cells and components of tumor microenvironment
Aymara Sancho-Araiz, Zinnia P Parra-Guillen, Jean Bragard, et al.
Pharmaceutical Research
|
December 21, 2021
Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis
Carolina Ameijeiras Rodríguez, Sara Carolina Henriques, Aymara Sancho-Araiz, et al.
Clinical Pharmacology and Therapeutics
|
May 12, 2023
Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling
Zinnia P Parra-Guillen, Aymara Sancho-Araiz, Kapil Mayawala, et al.
Cancers
|
October 23, 2021
Semi-Mechanistic Model for the Antitumor Response of a Combination Cocktail of Immuno-Modulators in Non-Inflamed (Cold) Tumors
Aymara Sancho-Araiz, Sara Zalba, María J Garrido, et al.
Pharmaceutics
|
November 25, 2023
Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases
Natalia Riva, Lucas Brstilo, Aymara Sancho-Araiz, et al.
Clinical Pharmacokinetics
|
May 21, 2026
Advancing Precision Dosing of 5-FU: Population PK Model Development, Limited Sampling Strategies, and Fit-for-Use Application
Zhiyuan Tan, Aymara Sancho-Araiz, Swantje Völler, et al.
Critical Care (London, England)
|
May 14, 2026
Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Adela Benítez-Cano, Aymara Sancho-Araiz, Jesús Carazo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmaceutics
|
August 10, 2021
The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives
Aymara Sancho-Araiz, Victor Mangas-Sanjuan, Iñaki F Trocóniz
Clinical Pharmacology and Therapeutics
|
July 22, 2024
Disentangling Anti-Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab
Aymara Sancho-Araiz, Zinnia P Parra-Guillen, Iñaki F Troconiz, et al.
Journal of Clinical Pharmacology
|
May 2, 2025
A Systematic Evaluation of the Dosing Regimens for Approved Targeted Therapies and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma From a Project OPTIMUS Perspective
Zhiyuan Tan, Swantje Völler, Aymara Sancho-Araiz, et al.
Plos Computational Biology
|
October 4, 2023
Mechanistic characterization of oscillatory patterns in unperturbed tumor growth dynamics: The interplay between cancer cells and components of tumor microenvironment
Aymara Sancho-Araiz, Zinnia P Parra-Guillen, Jean Bragard, et al.
Pharmaceutical Research
|
December 21, 2021
Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis
Carolina Ameijeiras Rodríguez, Sara Carolina Henriques, Aymara Sancho-Araiz, et al.
Clinical Pharmacology and Therapeutics
|
May 12, 2023
Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling
Zinnia P Parra-Guillen, Aymara Sancho-Araiz, Kapil Mayawala, et al.
Cancers
|
October 23, 2021
Semi-Mechanistic Model for the Antitumor Response of a Combination Cocktail of Immuno-Modulators in Non-Inflamed (Cold) Tumors
Aymara Sancho-Araiz, Sara Zalba, María J Garrido, et al.
Pharmaceutics
|
November 25, 2023
Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases
Natalia Riva, Lucas Brstilo, Aymara Sancho-Araiz, et al.
Clinical Pharmacokinetics
|
May 21, 2026
Advancing Precision Dosing of 5-FU: Population PK Model Development, Limited Sampling Strategies, and Fit-for-Use Application
Zhiyuan Tan, Aymara Sancho-Araiz, Swantje Völler, et al.
Critical Care (London, England)
|
May 14, 2026
Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Adela Benítez-Cano, Aymara Sancho-Araiz, Jesús Carazo, et al.
Page
of 1